slide1 n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Trial profile PowerPoint Presentation
Download Presentation
Trial profile

Loading in 2 Seconds...

play fullscreen
1 / 10

Trial profile - PowerPoint PPT Presentation


  • 83 Views
  • Uploaded on

Trial profile. Jonathan Mant, et al. Lancet 2007;370:493-503. Reasons why patients identified with atrial fibrillation did not take part in the study. Jonathan Mant, et al. Lancet 2007;370:493-503. Baseline characteristics of patients subsequently treated with warfarin or aspirin.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Trial profile' - tadeo


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
slide1

Trial profile

Jonathan Mant, et al. Lancet 2007;370:493-503

slide2

Reasons why patients identified with atrial fibrillation did not take part in the study

Jonathan Mant, et al. Lancet 2007;370:493-503

slide3

Baseline characteristics of patients subsequently treated with warfarin or aspirin

Jonathan Mant, et al. Lancet 2007;370:493-503

slide4

Kaplan-Meier plot of adherence to allocated treatment

Jonathan Mant, et al. Lancet 2007;370:493-503

slide5

Nature of primary events

Jonathan Mant, et al. Lancet 2007;370:493-503

slide6

Kaplan-Meier plot of time to primary event

Jonathan Mant, et al. Lancet 2007;370:493-503

slide7

Relative risk of all primary events by subgroup

Jonathan Mant, et al. Lancet 2007;370:493-503

slide8

Risk of primary event and major haemorrhage by treatment allocation for different patient subgroups

Jonathan Mant, et al. Lancet 2007;370:493-503

slide9

Risk of secondary and composite outcomes by treatment allocation for different patient subgroups

Jonathan Mant, et al. Lancet 2007;370:493-503

slide10

Indirect comparison of results from BAFTA for ischaemic stroke and major haemorrhage with results from six other randomised trials of aspirin versus anticoagulation

Jonathan Mant, et al. Lancet 2007;370:493-503